Strength Seen in Covance (CVD): Stock Surges 25.9% – Tale of the Tape

November 4, 2014 Technicals 0

Zacks

Covance Inc. (CVD) was a big mover last session with its shares surging nearly 26% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained nearly 26% in the past one-month time frame.

This drug development services company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate has also remained unchanged over the same period. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Covance currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks worth considering in the medical services industry are ICON plc (ICLR), BioTelemetry, Inc. (BEAT) and Charles River Laboratories International, Inc. (CRL). While ICON plc and BioTelemetry sport a Zacks Rank #1 (Strong Buy), Charles River Laboratories carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply